LCL161,
LCL161,
1005342-46-0,
LCL-161,
LCL 161,
UNII-6TNS415Y3P,
6TNS415Y3P,
CHEMBL2431768,
(s)-n-((s)-1-cyclohexyl-2-((s)-2-(4-(4-fluorobenzoyl)thiazol-2-yl)pyrrolidin-1-yl)-2-oxoethyl)-2-(methylamino)propanamide,
(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide,
Propanamide, N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-2-thiazolyl]-1-pyrrolidinyl]-2-oxoethyl]-2-(methylamino)-, (2S)-;Propanamide, N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-2-thiazolyl]-1-pyrrolidinyl]-2-oxoethyl]-2-(methylamino)-, (2S)-,
NVP-LCL161,
C26H33FN4O3S,
GTPL7912,
SCHEMBL1275369,
AOB4073,
EX-A533,
2508AH,
BDBM50441356,
MFCD23160049,
s7009,
ZINC95929260,
CS-1630,
DB12085,
SB19313,
BC600325,
HY-15518,
SC-94311,
J3.566.398C,
A11928,
Z-3226,
(S)-N-((S)-1-cyclohexyl-2-((S)-2-(4-(4-fluorobenzoyl)thiazol-2-yl)pyrrolidin-1,
(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-methylaminopropanamide,
Propanamide, N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-2-thiazolyl]-1-pyrrolidinyl]-2-oxoethyl]-2-(methylamino)-, (2S)-,
D0J7ZF,
A3541,
-yl)-2-oxoethyl)-2-(methylamino)propanamide,
LCL161, 98%, inhibitor of Apoptosis Protein (IAP) family of proteins - 100MG 100mg,
(S)-N-((S)-1-Cyclohexyl-2-{(S)-2-[4-(4-fluorobenzoyl)thiazol-2- yl]pyrrolidin-1-yl}-2-oxoethyl)-2-methylamino-propionamide,